Haoxuan Wang

Haoxuan Wang is a Senior Scientist at insitro since April 2024, leading early-stage ALS medicinal chemistry efforts and collaborating with teams focused on drug discovery. Previously, Haoxuan served as a Senior Scientist I at MOMA Therapeutics, specializing in small molecule inhibitors for molecular machines. At Vertex Pharmaceuticals, Haoxuan worked as a Research Scientist II on small molecule drug discovery aimed at rare diseases. Experience at Amgen involved designing novel small molecules for neurodegenerative diseases, while a postdoctoral association at the Massachusetts Institute of Technology (MIT) focused on developing strategies for enantioenriched N-alkyl aziridines. Education includes a PhD in Organic Chemistry from Caltech and a BS in Chemistry from Fudan University.